Bausch Health Companies Inc. shares rise 2.68% intraday after Viatris Inc. appoints David Simmons to its Board of Directors.

martes, 5 de agosto de 2025, 10:07 am ET1 min de lectura
BHC--
Bausch Health Companies Inc. rose 2.68% intraday. The company's stock price increase may be attributed to the appointment of David Simmons to Viatris' Board of Directors, which could potentially lead to strategic benefits for Bausch Health Companies Inc. as Simmons has extensive pharmaceutical industry experience and executive expertise.

Bausch Health Companies Inc. shares rise 2.68% intraday after Viatris Inc. appoints David Simmons to its Board of Directors.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios